Clinical Trials Logo

Clinical Trial Summary

Fronto-Temporal Lobar Degeneration (FTLD) refers to 3 categories of neurodegenerative diseases generally occurring between 55 and 65 years: Fronto-Temporal Dementia(FTD), Primary Progressive Aphasia (PPA), Semantic Dementia (SD). Clinical expression is substantially variable among individuals, but in most cases, behavioural disorders and personality changes are prominent. FTLD is poorly known by general public including health care professionals. Currently, the French health system does not meet the needs and expectations of patients and their families


Clinical Trial Description

Patients with FTLD and their caregivers need to be recognized and supported through specific and tailored made actions provided by expert teams. The main objective of our study is to evaluate the effectiveness of a 6-month personalized multidisciplinary care provided to the dyad FTLD patient and caregiver on patient's behavioural disorders. The secondary objectives are to assess the impact of this program on patient's cognitive deterioration, functional autonomy and behavioral problems, as well as caregiver's depressive symptomatology and sense of competence ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03606798
Study type Interventional
Source University Hospital, Bordeaux
Contact
Status Completed
Phase N/A
Start date June 21, 2018
Completion date October 6, 2021

See also
  Status Clinical Trial Phase
Completed NCT01925196 - Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation
Active, not recruiting NCT04516499 - Neurofilament Surveillance Project (NSP)
Recruiting NCT05456503 - PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using PI-2620 Phase 3
Recruiting NCT03030586 - ADDIA Proof-of-Performance Clinical Study
Completed NCT02590276 - Predict to Prevent Frontotemporal Lobar Degeneration (FDT) and Amyotrophic Lateral Sclerosis (ALS) N/A
Completed NCT00677885 - P-glycoprotein Function in Brain Diseases
Completed NCT02333942 - Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia
Completed NCT00187525 - A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration Phase 4
Recruiting NCT05741853 - Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia N/A
Completed NCT04287738 - Care Ecosystem: Navigating Patients and Families Through Stages of Care, Extension Trial N/A
Completed NCT02213458 - Care Ecosystem: Navigating Patients and Families Through Stages of Care N/A
Active, not recruiting NCT04937452 - Dopaminergic Therapy for Frontotemporal Dementia Patients Phase 2
Recruiting NCT01962064 - Social Cognition in Ageing and in Frontotemporal Lobar Degeneration N/A
Recruiting NCT05956834 - A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
Completed NCT00088751 - Treatment Study of Frontotemporal Dementia N/A
Enrolling by invitation NCT04635540 - Decreased Empathy and Emotion Recognition in Patients With Neurodegenerative Disease N/A
Completed NCT00604591 - Effects of Tolcapone on Frontotemporal Dementia Phase 2
Completed NCT03508024 - Patients With Alzheimer's Disease or Related Youth Disease
Completed NCT00613119 - PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Frontotemporal Dementia
Recruiting NCT02964611 - Social Cognition and Personality Changes in Alzheimer's & Parkinson's Disease & Frontotemporal Lobar Degeneration